Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DPYSL4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | ZNF470 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ACVR2B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | AEBP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ST8SIA4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | NRIP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | IQGAP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SERINC3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SOCS4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SAMD14 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |